1-6 of 6
Authors: Frank Hsu
Journal Article
SURG-56. TRANSCRIPTION FACTOR CELL LINEAGE DETERMINES AGGRESSIVE BEHAVIOR AMONG NONFUNCTIONAL PITUITARY ADENOMAS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii286–viii287, https://doi.org/10.1093/neuonc/noae165.1135
Published: 11 November 2024
Journal Article
EPID-35. COLLISION TUMORS AT THE SKULL BASE: UNVEILING A PETROCLIVAL MENINGIOMA COEXISTING WITH A GROWTH HORMONE-PRODUCING PITUITARY ADENOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii145–viii146, https://doi.org/10.1093/neuonc/noae165.0571
Published: 11 November 2024
Journal Article
SURG-30. SURGICAL MANAGEMENT OF A RARE SACROCOCCYGEAL MYXOPAPILLARY EPENDYMOMA OF THE GLUTEAL REGION: CASE ILLUSTRATION AND SYSTEMATIC LITERATURE REVIEW Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii258, https://doi.org/10.1093/neuonc/noac209.995
Published: 14 November 2022
Journal Article
CTIM-33. PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1) Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi58, https://doi.org/10.1093/neuonc/noab196.225
Published: 12 November 2021
Journal Article
CTIM-26. PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii38–ii39, https://doi.org/10.1093/neuonc/noaa215.160
Published: 09 November 2020
Journal Article
CTIM-09. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: VACCINE OVERALL SURVIVAL IN BEVACIZUMAB NAIVE AND BEVACIZUMAB RESISTANT PATIENTS Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii34, https://doi.org/10.1093/neuonc/noaa215.143
Published: 09 November 2020
